MAPT and Alzheimer disease: We thus ventured to decipher whether LC axon degeneration is evident in post-mortem tissue from OBs of early AD cases, staged by Aβ and tau immunostainings (Thal-phase 1-2, Braak stage 1-2) and unaffected control brain donors.